Stocks and Investing
Stocks and Investing
Fri, July 18, 2014
[ Fri, Jul 18th 2014
] - WOPRAI
[ Fri, Jul 18th 2014
] - WOPRAI
[ Fri, Jul 18th 2014
] - WOPRAI
[ Fri, Jul 18th 2014
] - WOPRAI
[ Fri, Jul 18th 2014
] - WOPRAI
[ Fri, Jul 18th 2014
] - WOPRAI
[ Fri, Jul 18th 2014
] - WOPRAI
[ Fri, Jul 18th 2014
] - WOPRAI
[ Fri, Jul 18th 2014
] - WOPRAI
[ Fri, Jul 18th 2014
] - WOPRAI
[ Fri, Jul 18th 2014
] - WOPRAI
[ Fri, Jul 18th 2014
] - WOPRAI
[ Fri, Jul 18th 2014
] - WOPRAI
[ Fri, Jul 18th 2014
] - WOPRAI
[ Fri, Jul 18th 2014
] - WOPRAI
[ Fri, Jul 18th 2014
] - WOPRAI
[ Fri, Jul 18th 2014
] - WOPRAI
[ Fri, Jul 18th 2014
] - WOPRAI
Thu, July 17, 2014
[ Thu, Jul 17th 2014
] - WOPRAI
[ Thu, Jul 17th 2014
] - WOPRAI
[ Thu, Jul 17th 2014
] - WOPRAI
[ Thu, Jul 17th 2014
] - WOPRAI
[ Thu, Jul 17th 2014
] - WOPRAI
[ Thu, Jul 17th 2014
] - WOPRAI
[ Thu, Jul 17th 2014
] - WOPRAI
[ Thu, Jul 17th 2014
] - WOPRAI
Jayson Bedford Maintained (ABT) at Buy with Increased Target to $46 on, Jul 17th, 2014
Jayson Bedford of Raymond James, Maintained "Abbott Laboratories" (ABT) at Buy with Increased Target from $44 to $46 on, Jul 17th, 2014.
Jayson has made no other calls on ABT in the last 4 months.
There is 1 other peer that has a rating on ABT. Out of the 1 peers that are also analyzing ABT, 0 agree with Jayson's Rating of Hold.
This is the rating of the analyst that currently disagrees with Jayson
- Matt Miksic of "Credit Suisse" Upgraded from Hold to Buy on, Monday, May 19th, 2014
Contributing Sources
Similar Stocks and Investing Articles
[ Thu, Jun 19th 2014
] - WOPRAI
[ Wed, May 07th 2014
] - WOPRAI
[ Fri, May 02nd 2014
] - WOPRAI
[ Wed, Jan 15th 2014
] - WOPRAI
[ Thu, Apr 18th 2013
] - WOPRAI
[ Fri, Jul 06th 2012
] - WOPRAI
[ Mon, Jul 02nd 2012
] - WOPRAI
[ Tue, May 15th 2012
] - WOPRAI
[ Wed, Mar 21st 2012
] - WOPRAI